HEADER TRANSFERASE 10-SEP-20 7ACD TITLE CRYSTAL STRUCTURE OF THE HUMAN METTL3-METTL14 COMPLEX WITH COMPOUND TITLE 2 T30 (UZH1A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: N6-ADENOSINE-METHYLTRANSFERASE CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: METHYLTRANSFERASE-LIKE PROTEIN 3,HMETTL3,N6-ADENOSINE- COMPND 5 METHYLTRANSFERASE 70 KDA SUBUNIT,MT-A70; COMPND 6 EC: 2.1.1.348; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: N6-ADENOSINE-METHYLTRANSFERASE NON-CATALYTIC SUBUNIT; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: METHYLTRANSFERASE-LIKE PROTEIN 14,HMETTL14; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: METTL3, MTA70; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: METTL14, KIAA1627; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, COMPLEX, METTL3, SINEFUNGIN, METTL14, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.K.BEDI,D.HUANG,A.CAFLISCH REVDAT 7 31-JAN-24 7ACD 1 JRNL REVDAT 6 13-OCT-21 7ACD 1 JRNL REVDAT 5 21-JUL-21 7ACD 1 JRNL REVDAT 4 24-MAR-21 7ACD 1 COMPND JRNL REMARK SHEET REVDAT 4 2 1 SSBOND LINK ATOM REVDAT 3 11-NOV-20 7ACD 1 JRNL REVDAT 2 04-NOV-20 7ACD 1 JRNL REVDAT 1 28-OCT-20 7ACD 0 JRNL AUTH E.V.MOROZ-OMORI,D.HUANG,R.KUMAR BEDI,S.J.CHERIYAMKUNNEL, JRNL AUTH 2 E.BOCHENKOVA,A.DOLBOIS,M.D.RZECZKOWSKI,Y.LI,L.WIEDMER, JRNL AUTH 3 A.CAFLISCH JRNL TITL METTL3 INHIBITORS FOR EPITRANSCRIPTOMIC MODULATION OF JRNL TITL 2 CELLULAR PROCESSES. JRNL REF CHEMMEDCHEM V. 16 3035 2021 JRNL REFN ESSN 1860-7187 JRNL PMID 34237194 JRNL DOI 10.1002/CMDC.202100291 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.V.MOROZ-OMORI,D.HUANG,R.K.BEDI,S.J.CHERIYAMKUNNEL, REMARK 1 AUTH 2 E.BOCHENKOVA,A.DOLBOIS,M.D.RZECZKOWSKI,L.WIEDMER,A.CAFLISCH REMARK 1 TITL METTL3 INHIBITORS FOR EPITRANSCRIPTOMIC MODULATION OF REMARK 1 TITL 2 CELLULAR PROCESSES REMARK 1 REF BIORXIV 2020 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2020.09.25.311803 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.LI,R.K.BEDI,E.V.MOROZ-OMORI,A.CAFLISCH REMARK 1 TITL STRUCTURAL AND DYNAMIC INSIGHTS INTO REDUNDANT FUNCTION OF REMARK 1 TITL 2 YTHDF PROTEINS. REMARK 1 REF J CHEM INF MODEL 2020 REMARK 1 REFN ESSN 1549-960X REMARK 1 PMID 33073985 REMARK 1 DOI 10.1021/ACS.JCIM.0C01029 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 19162 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 959 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.4800 - 4.7900 1.00 2786 147 0.1859 0.2035 REMARK 3 2 4.7800 - 3.8000 1.00 2620 138 0.1457 0.1659 REMARK 3 3 3.8000 - 3.3200 1.00 2594 137 0.1731 0.2440 REMARK 3 4 3.3200 - 3.0200 1.00 2571 135 0.2031 0.2585 REMARK 3 5 3.0200 - 2.8000 1.00 2559 135 0.2426 0.3195 REMARK 3 6 2.8000 - 2.6300 1.00 2522 133 0.2454 0.3359 REMARK 3 7 2.6300 - 2.5000 1.00 2551 134 0.2382 0.3135 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.312 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.911 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3594 REMARK 3 ANGLE : 1.065 4897 REMARK 3 CHIRALITY : 0.056 531 REMARK 3 PLANARITY : 0.008 632 REMARK 3 DIHEDRAL : 16.045 488 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ACD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1292111192. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 44.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.720 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5L6D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 400MM MG ACETATE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 149.94667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.97333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 74.97333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 149.94667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 744 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 579 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 335 REMARK 465 GLY A 336 REMARK 465 HIS A 337 REMARK 465 HIS A 338 REMARK 465 HIS A 339 REMARK 465 HIS A 340 REMARK 465 HIS A 341 REMARK 465 HIS A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 ARG A 346 REMARK 465 GLU A 347 REMARK 465 ASN A 348 REMARK 465 LEU A 349 REMARK 465 TYR A 350 REMARK 465 PHE A 351 REMARK 465 GLN A 352 REMARK 465 GLY A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 THR A 356 REMARK 465 GLN A 357 REMARK 465 SER A 358 REMARK 465 VAL A 359 REMARK 465 GLY A 360 REMARK 465 GLY A 361 REMARK 465 ASP A 362 REMARK 465 SER A 363 REMARK 465 SER A 364 REMARK 465 ALA A 365 REMARK 465 ASP A 366 REMARK 465 ARG A 367 REMARK 465 MET A 402 REMARK 465 ARG A 468 REMARK 465 THR A 469 REMARK 465 GLY A 470 REMARK 465 ARG A 471 REMARK 465 THR A 472 REMARK 465 GLY A 473 REMARK 465 PRO A 577 REMARK 465 LYS A 578 REMARK 465 ASN A 579 REMARK 465 LEU A 580 REMARK 465 MET B 106 REMARK 465 LEU B 107 REMARK 465 LYS B 108 REMARK 465 GLY B 109 REMARK 465 THR B 110 REMARK 465 GLN B 111 REMARK 465 SER B 112 REMARK 465 LEU B 113 REMARK 465 ASN B 114 REMARK 465 PRO B 115 REMARK 465 HIS B 116 REMARK 465 VAL B 137 REMARK 465 GLY B 138 REMARK 465 LEU B 139 REMARK 465 ALA B 140 REMARK 465 ASP B 141 REMARK 465 ARG B 142 REMARK 465 PHE B 143 REMARK 465 GLU B 144 REMARK 465 GLU B 145 REMARK 465 TYR B 146 REMARK 465 PRO B 147 REMARK 465 LYS B 148 REMARK 465 LEU B 149 REMARK 465 GLU B 201 REMARK 465 THR B 202 REMARK 465 GLY B 203 REMARK 465 ILE B 204 REMARK 465 THR B 205 REMARK 465 ALA B 206 REMARK 465 ASN B 207 REMARK 465 GLU B 208 REMARK 465 GLY B 270 REMARK 465 LYS B 271 REMARK 465 THR B 272 REMARK 465 LYS B 273 REMARK 465 THR B 274 REMARK 465 VAL B 296 REMARK 465 LYS B 297 REMARK 465 ARG B 298 REMARK 465 SER B 299 REMARK 465 THR B 300 REMARK 465 ASP B 301 REMARK 465 GLY B 302 REMARK 465 ASP B 303 REMARK 465 PHE B 304 REMARK 465 ILE B 305 REMARK 465 HIS B 306 REMARK 465 ALA B 307 REMARK 465 ASN B 308 REMARK 465 ILE B 392 REMARK 465 GLU B 393 REMARK 465 ARG B 394 REMARK 465 LEU B 395 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LEU A 404 CG CD1 CD2 REMARK 470 TYR A 406 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 462 CG CD OE1 NE2 REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 474 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 508 CG CD NE CZ NH1 NH2 REMARK 470 SER A 509 OG REMARK 470 THR A 510 OG1 CG2 REMARK 470 LYS A 566 CG CD CE NZ REMARK 470 ILE A 573 CG1 CG2 CD1 REMARK 470 LYS A 576 CG CD CE NZ REMARK 470 ARG B 135 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 150 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 151 CG CD OE1 OE2 REMARK 470 LEU B 152 CG CD1 CD2 REMARK 470 ILE B 153 CG1 CG2 CD1 REMARK 470 ARG B 154 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 155 CG CD1 CD2 REMARK 470 GLU B 158 CG CD OE1 OE2 REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 200 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 209 CG CD CE NZ REMARK 470 GLU B 220 CG CD OE1 OE2 REMARK 470 ARG B 228 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 309 CG1 CG2 REMARK 470 GLU B 320 CG CD OE1 OE2 REMARK 470 GLU B 325 CG CD OE1 OE2 REMARK 470 GLU B 372 CG CD OE1 OE2 REMARK 470 TYR B 384 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 390 CG CD OE1 OE2 REMARK 470 GLU B 391 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 727 O HOH A 737 2.05 REMARK 500 O THR B 295 O HOH B 501 2.09 REMARK 500 O HOH B 517 O HOH B 561 2.11 REMARK 500 O HOH B 565 O HOH B 570 2.12 REMARK 500 O HOH B 503 O HOH B 545 2.14 REMARK 500 O LYS A 576 O HOH A 701 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 418 47.73 -90.48 REMARK 500 VAL A 507 102.43 -58.93 REMARK 500 ARG A 508 -91.32 -73.19 REMARK 500 LEU A 557 -31.69 -137.18 REMARK 500 PRO B 184 -165.15 -74.57 REMARK 500 GLU B 220 53.27 -90.14 REMARK 500 SER B 237 14.32 -152.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 368 PHE A 369 -141.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 743 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH A 744 DISTANCE = 7.48 ANGSTROMS REMARK 525 HOH B 579 DISTANCE = 6.44 ANGSTROMS DBREF 7ACD A 354 580 UNP Q86U44 MTA70_HUMAN 354 580 DBREF 7ACD B 107 395 UNP Q9HCE5 MET14_HUMAN 107 395 SEQADV 7ACD MET A 335 UNP Q86U44 INITIATING METHIONINE SEQADV 7ACD GLY A 336 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 337 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 338 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 339 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 340 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 341 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD HIS A 342 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD SER A 343 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD SER A 344 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD GLY A 345 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD ARG A 346 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD GLU A 347 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD ASN A 348 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD LEU A 349 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD TYR A 350 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD PHE A 351 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD GLN A 352 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD GLY A 353 UNP Q86U44 EXPRESSION TAG SEQADV 7ACD MET B 106 UNP Q9HCE5 INITIATING METHIONINE SEQRES 1 A 246 MET GLY HIS HIS HIS HIS HIS HIS SER SER GLY ARG GLU SEQRES 2 A 246 ASN LEU TYR PHE GLN GLY ALA LEU THR GLN SER VAL GLY SEQRES 3 A 246 GLY ASP SER SER ALA ASP ARG LEU PHE PRO PRO GLN TRP SEQRES 4 A 246 ILE CYS CYS ASP ILE ARG TYR LEU ASP VAL SER ILE LEU SEQRES 5 A 246 GLY LYS PHE ALA VAL VAL MET ALA ASP PRO PRO TRP ASP SEQRES 6 A 246 ILE HIS MET GLU LEU PRO TYR GLY THR LEU THR ASP ASP SEQRES 7 A 246 GLU MET ARG ARG LEU ASN ILE PRO VAL LEU GLN ASP ASP SEQRES 8 A 246 GLY PHE LEU PHE LEU TRP VAL THR GLY ARG ALA MET GLU SEQRES 9 A 246 LEU GLY ARG GLU CYS LEU ASN LEU TRP GLY TYR GLU ARG SEQRES 10 A 246 VAL ASP GLU ILE ILE TRP VAL LYS THR ASN GLN LEU GLN SEQRES 11 A 246 ARG ILE ILE ARG THR GLY ARG THR GLY HIS TRP LEU ASN SEQRES 12 A 246 HIS GLY LYS GLU HIS CYS LEU VAL GLY VAL LYS GLY ASN SEQRES 13 A 246 PRO GLN GLY PHE ASN GLN GLY LEU ASP CYS ASP VAL ILE SEQRES 14 A 246 VAL ALA GLU VAL ARG SER THR SER HIS LYS PRO ASP GLU SEQRES 15 A 246 ILE TYR GLY MET ILE GLU ARG LEU SER PRO GLY THR ARG SEQRES 16 A 246 LYS ILE GLU LEU PHE GLY ARG PRO HIS ASN VAL GLN PRO SEQRES 17 A 246 ASN TRP ILE THR LEU GLY ASN GLN LEU ASP GLY ILE HIS SEQRES 18 A 246 LEU LEU ASP PRO ASP VAL VAL ALA ARG PHE LYS GLN ARG SEQRES 19 A 246 TYR PRO ASP GLY ILE ILE SER LYS PRO LYS ASN LEU SEQRES 1 B 290 MET LEU LYS GLY THR GLN SER LEU ASN PRO HIS ASN ASP SEQRES 2 B 290 TYR CYS GLN HIS PHE VAL ASP THR GLY HIS ARG PRO GLN SEQRES 3 B 290 ASN PHE ILE ARG ASP VAL GLY LEU ALA ASP ARG PHE GLU SEQRES 4 B 290 GLU TYR PRO LYS LEU ARG GLU LEU ILE ARG LEU LYS ASP SEQRES 5 B 290 GLU LEU ILE ALA LYS SER ASN THR PRO PRO MET TYR LEU SEQRES 6 B 290 GLN ALA ASP ILE GLU ALA PHE ASP ILE ARG GLU LEU THR SEQRES 7 B 290 PRO LYS PHE ASP VAL ILE LEU LEU GLU PRO PRO LEU GLU SEQRES 8 B 290 GLU TYR TYR ARG GLU THR GLY ILE THR ALA ASN GLU LYS SEQRES 9 B 290 CYS TRP THR TRP ASP ASP ILE MET LYS LEU GLU ILE ASP SEQRES 10 B 290 GLU ILE ALA ALA PRO ARG SER PHE ILE PHE LEU TRP CYS SEQRES 11 B 290 GLY SER GLY GLU GLY LEU ASP LEU GLY ARG VAL CYS LEU SEQRES 12 B 290 ARG LYS TRP GLY TYR ARG ARG CYS GLU ASP ILE CYS TRP SEQRES 13 B 290 ILE LYS THR ASN LYS ASN ASN PRO GLY LYS THR LYS THR SEQRES 14 B 290 LEU ASP PRO LYS ALA VAL PHE GLN ARG THR LYS GLU HIS SEQRES 15 B 290 CYS LEU MET GLY ILE LYS GLY THR VAL LYS ARG SER THR SEQRES 16 B 290 ASP GLY ASP PHE ILE HIS ALA ASN VAL ASP ILE ASP LEU SEQRES 17 B 290 ILE ILE THR GLU GLU PRO GLU ILE GLY ASN ILE GLU LYS SEQRES 18 B 290 PRO VAL GLU ILE PHE HIS ILE ILE GLU HIS PHE CYS LEU SEQRES 19 B 290 GLY ARG ARG ARG LEU HIS LEU PHE GLY ARG ASP SER THR SEQRES 20 B 290 ILE ARG PRO GLY TRP LEU THR VAL GLY PRO THR LEU THR SEQRES 21 B 290 ASN SER ASN TYR ASN ALA GLU THR TYR ALA SER TYR PHE SEQRES 22 B 290 SER ALA PRO ASN SER TYR LEU THR GLY CYS THR GLU GLU SEQRES 23 B 290 ILE GLU ARG LEU HET R72 A 601 41 HET MG B 401 1 HET ACT B 402 4 HETNAM R72 4-[(4,4-DIMETHYLPIPERIDIN-1-YL)METHYL]-2-OXIDANYL-~{N}- HETNAM 2 R72 [[(3~{R})-3-OXIDANYL-1-[6-[(PHENYLMETHYL) HETNAM 3 R72 AMINO]PYRIMIDIN-4-YL]PIPERIDIN-3-YL]METHYL]BENZAMIDE HETNAM MG MAGNESIUM ION HETNAM ACT ACETATE ION FORMUL 3 R72 C32 H42 N6 O3 FORMUL 4 MG MG 2+ FORMUL 5 ACT C2 H3 O2 1- FORMUL 6 HOH *123(H2 O) HELIX 1 AA1 ASP A 382 GLY A 387 5 6 HELIX 2 AA2 THR A 410 LEU A 417 1 8 HELIX 3 AA3 ASN A 418 LEU A 422 5 5 HELIX 4 AA4 ARG A 435 TRP A 447 1 13 HELIX 5 AA5 ASP A 515 SER A 525 1 11 HELIX 6 AA6 ARG A 536 VAL A 540 5 5 HELIX 7 AA7 ASP A 558 TYR A 569 1 12 HELIX 8 AA8 ASP B 118 GLY B 127 1 10 HELIX 9 AA9 ARG B 129 ILE B 134 5 6 HELIX 10 AB1 LEU B 152 ASN B 164 1 13 HELIX 11 AB2 ASP B 178 LEU B 182 5 5 HELIX 12 AB3 LEU B 195 TYR B 199 5 5 HELIX 13 AB4 THR B 212 LYS B 218 1 7 HELIX 14 AB5 LEU B 219 GLU B 223 5 5 HELIX 15 AB6 GLU B 239 GLY B 252 1 14 HELIX 16 AB7 VAL B 328 PHE B 337 1 10 HELIX 17 AB8 ARG B 349 ILE B 353 5 5 HELIX 18 AB9 ASN B 370 TYR B 377 1 8 SHEET 1 AA1 9 VAL A 502 GLU A 506 0 SHEET 2 AA1 9 GLU A 450 THR A 460 1 N VAL A 458 O ILE A 503 SHEET 3 AA1 9 LYS A 480 LYS A 488 -1 O CYS A 483 N ILE A 455 SHEET 4 AA1 9 GLY A 426 VAL A 432 -1 N LEU A 430 O LEU A 484 SHEET 5 AA1 9 VAL A 391 ALA A 394 1 N ALA A 394 O PHE A 429 SHEET 6 AA1 9 LYS A 530 LEU A 533 1 O ILE A 531 N MET A 393 SHEET 7 AA1 9 TRP A 544 GLY A 548 1 O ILE A 545 N GLU A 532 SHEET 8 AA1 9 GLN A 372 CYS A 375 1 N GLN A 372 O THR A 546 SHEET 9 AA1 9 ILE A 554 HIS A 555 -1 O HIS A 555 N TRP A 373 SHEET 1 AA2 8 MET B 168 GLN B 171 0 SHEET 2 AA2 8 LEU B 358 GLY B 361 1 O THR B 359 N MET B 168 SHEET 3 AA2 8 ARG B 343 LEU B 346 1 N HIS B 345 O LEU B 358 SHEET 4 AA2 8 PHE B 186 LEU B 191 1 N LEU B 190 O LEU B 344 SHEET 5 AA2 8 ALA B 225 GLY B 236 1 O PHE B 232 N LEU B 191 SHEET 6 AA2 8 LYS B 285 LYS B 293 -1 O HIS B 287 N CYS B 235 SHEET 7 AA2 8 ARG B 254 THR B 264 -1 N TRP B 261 O GLU B 286 SHEET 8 AA2 8 LEU B 313 GLU B 317 1 O ILE B 314 N ILE B 262 SSBOND 1 CYS B 338 CYS B 388 1555 1555 2.03 LINK OD2 ASP B 157 MG MG B 401 1555 1555 2.98 CISPEP 1 THR B 183 PRO B 184 0 0.02 CISPEP 2 ALA B 380 PRO B 381 0 3.61 CRYST1 63.800 63.800 224.920 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015674 0.009049 0.000000 0.00000 SCALE2 0.000000 0.018099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004446 0.00000